韩国成人失眠的诊断和治疗的临床实践指南

2020-11-04 韩国医学指南信息中心 韩国医学指南信息中心

本指南的目的是协助进行循证失眠治疗的临床医生。

中文标题:

韩国成人失眠的诊断和治疗的临床实践指南

英文标题:

Korean Clinical Practice Guideline for the Diagnosis and Treatment of Insomnia in Adults

发布日期:

2020-11-04

简要介绍:

本指南的目的是协助进行循证失眠治疗的临床医生。

方法:我们从循证实践指南中选择了可能适合用于指南制定的文献。 在过去五年中由学术或政府机构发行。

结果:使用《研究与评估指南评估》(AGREE)II工具评估了三项临床评估的质量 准则。指南制定过​​程的最终结果是总共15条建议,它们报告了建议的强度,证据的质量,内容的摘要以及在应用建议时的注意事项。

结论:制定和不断更新失眠临床指南至关重要,以提供更准确的信息 对患者的循证治疗。

相关资料下载:
[AttachmentFileName(sort=1, fileName=66.pdf)] GetToolGuiderByIdResponse(projectId=1, id=7b1321c002010922, title=韩国成人失眠的诊断和治疗的临床实践指南, enTitle=Korean Clinical Practice Guideline for the Diagnosis and Treatment of Insomnia in Adults , guiderFrom=韩国医学指南信息中心, authorId=0, author=, summary=本指南的目的是协助进行循证失眠治疗的临床医生。, cover=, journalId=0, articlesId=null, associationId=1928, associationName=韩国医学指南信息中心, associationIntro=Korean Medical Guideline Information Center (KoMGI), copyright=0, guiderPublishedTime=Wed Nov 04 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p>本指南的目的是协助进行循证失眠治疗的临床医生。</p> <p>方法:我们从循证实践指南中选择了可能适合用于指南制定的文献。 在过去五年中由学术或政府机构发行。</p> <p>结果:使用《研究与评估指南评估》(AGREE)II工具评估了三项临床评估的质量 准则。指南制定过​​程的最终结果是总共15条建议,它们报告了建议的强度,证据的质量,内容的摘要以及在应用建议时的注意事项。</p> <p>结论:制定和不断更新失眠临床指南至关重要,以提供更准确的信息 对患者的循证治疗。</p>, tagList=[TagDto(tagId=1365, tagName=失眠)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2410, appHits=154, showAppHits=0, pcHits=551, showPcHits=2256, likes=1, shares=16, comments=10, approvalStatus=1, publishedTime=Mon Nov 23 10:19:24 CST 2020, publishedTimeString=2020-11-04, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=fbzhang, createdTime=Mon Nov 23 10:18:19 CST 2020, updatedBy=4754896, updatedName=fbzhang, updatedTime=Tue Jan 02 15:28:08 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=66.pdf)])
66.pdf
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1196338, encodeId=841c119633826, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3705584500, createdName=ms5000000000236817, createdTime=Wed Feb 23 10:06:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078773, encodeId=9d5610e87736d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f0c2256555, createdName=12175fd8m91暂无昵称, createdTime=Fri Dec 10 14:17:09 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006240, encodeId=0c92100624064, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19575559330, createdName=xuzh0307, createdTime=Mon Aug 09 09:23:11 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947991, encodeId=868894e9913c, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210314/f876cc88ef194e2da08c0f66ce678ab1/cb673c54ea2948139c76d869c116f07b.jpg, createdBy=07525468833, createdName=ms4000001598728459, createdTime=Sun Mar 14 07:59:32 CST 2021, time=2021-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901863, encodeId=b15790186307, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a885197331, createdName=Venusyao, createdTime=Tue Nov 24 18:20:50 CST 2020, time=2020-11-24, status=1, ipAttribution=)]
    2022-02-23 ms5000000000236817

    学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1196338, encodeId=841c119633826, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3705584500, createdName=ms5000000000236817, createdTime=Wed Feb 23 10:06:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078773, encodeId=9d5610e87736d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f0c2256555, createdName=12175fd8m91暂无昵称, createdTime=Fri Dec 10 14:17:09 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006240, encodeId=0c92100624064, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19575559330, createdName=xuzh0307, createdTime=Mon Aug 09 09:23:11 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947991, encodeId=868894e9913c, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210314/f876cc88ef194e2da08c0f66ce678ab1/cb673c54ea2948139c76d869c116f07b.jpg, createdBy=07525468833, createdName=ms4000001598728459, createdTime=Sun Mar 14 07:59:32 CST 2021, time=2021-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901863, encodeId=b15790186307, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a885197331, createdName=Venusyao, createdTime=Tue Nov 24 18:20:50 CST 2020, time=2020-11-24, status=1, ipAttribution=)]
    2021-12-10 12175fd8m91暂无昵称

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1196338, encodeId=841c119633826, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3705584500, createdName=ms5000000000236817, createdTime=Wed Feb 23 10:06:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078773, encodeId=9d5610e87736d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f0c2256555, createdName=12175fd8m91暂无昵称, createdTime=Fri Dec 10 14:17:09 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006240, encodeId=0c92100624064, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19575559330, createdName=xuzh0307, createdTime=Mon Aug 09 09:23:11 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947991, encodeId=868894e9913c, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210314/f876cc88ef194e2da08c0f66ce678ab1/cb673c54ea2948139c76d869c116f07b.jpg, createdBy=07525468833, createdName=ms4000001598728459, createdTime=Sun Mar 14 07:59:32 CST 2021, time=2021-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901863, encodeId=b15790186307, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a885197331, createdName=Venusyao, createdTime=Tue Nov 24 18:20:50 CST 2020, time=2020-11-24, status=1, ipAttribution=)]
    2021-08-09 xuzh0307

    积分

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1196338, encodeId=841c119633826, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3705584500, createdName=ms5000000000236817, createdTime=Wed Feb 23 10:06:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078773, encodeId=9d5610e87736d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f0c2256555, createdName=12175fd8m91暂无昵称, createdTime=Fri Dec 10 14:17:09 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006240, encodeId=0c92100624064, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19575559330, createdName=xuzh0307, createdTime=Mon Aug 09 09:23:11 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947991, encodeId=868894e9913c, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210314/f876cc88ef194e2da08c0f66ce678ab1/cb673c54ea2948139c76d869c116f07b.jpg, createdBy=07525468833, createdName=ms4000001598728459, createdTime=Sun Mar 14 07:59:32 CST 2021, time=2021-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901863, encodeId=b15790186307, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a885197331, createdName=Venusyao, createdTime=Tue Nov 24 18:20:50 CST 2020, time=2020-11-24, status=1, ipAttribution=)]
    2021-03-14 ms4000001598728459

    积分

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1196338, encodeId=841c119633826, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3705584500, createdName=ms5000000000236817, createdTime=Wed Feb 23 10:06:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078773, encodeId=9d5610e87736d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f0c2256555, createdName=12175fd8m91暂无昵称, createdTime=Fri Dec 10 14:17:09 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006240, encodeId=0c92100624064, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19575559330, createdName=xuzh0307, createdTime=Mon Aug 09 09:23:11 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947991, encodeId=868894e9913c, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210314/f876cc88ef194e2da08c0f66ce678ab1/cb673c54ea2948139c76d869c116f07b.jpg, createdBy=07525468833, createdName=ms4000001598728459, createdTime=Sun Mar 14 07:59:32 CST 2021, time=2021-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901863, encodeId=b15790186307, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a885197331, createdName=Venusyao, createdTime=Tue Nov 24 18:20:50 CST 2020, time=2020-11-24, status=1, ipAttribution=)]
    2020-11-24 Venusyao

    积分

    0